CTGCT
  • en
    • si
  • About us
    • About CTGCT
    • Partners
    • CTGCT Days 2025
    • Funding of the CTGCT
  • Job Openings
  • Products and Services
  • Learning Box
    • Learning Box
    • CTGCT Science Talks
    • Publications
  • POSTS
    • Events
    • Articles
    • News
    • All posts
  • Get in touch

Rodrigo Ortiz

  • Articles
  • Clinicians
  • Pacients
  • Researchers
  • Gen Therapy
  • Research
  • Rodrigo Ortiz
5 June 2025

Unraveling the Mysteries of NLRP3: A Key Player in Inflammation

In the complex world of cellular biology, proteins play a crucial role in maintaining our body's health and responding to threats. One such protein, NLRP3, is known for its ability to assemble the inflammasome ...

Nlrp3 Paper
  • Articles
  • Clinicians
  • Pacients
  • Researchers
  • Cell therapy
  • Gen Therapy
  • Laboratory
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
3 June 2025

Harnessing Synthetic Biology for Innovative Medical Treatments

In the world of synthetic biology, scientists are pushing the boundaries of what's possible by designing proteins that can be controlled in specific ways. This review written by Tjaša Plaper, Urška Knez Štibler and ...

Synthetic biology Review
  • Articles
  • Clinicians
  • Pacients
  • Researchers
  • Cell therapy
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
28 May 2025

How Ultrasound Can Control Cells, the Future of Medicine?

Members of our team have already published work on sonogenetics (check our article breaking down that research here). We think this could have interesting applications in the future, since it overcomes the issue of ...

Review Sonogenetics
  • Events
  • Clinicians
  • Pacients
  • Researchers
  • Charite Berlin
  • CTGCT
  • NIC
  • TUD
  • UCL
  • UMCUtrecht
  • Rodrigo Ortiz
19 May 2025 Event Date: 15 May 2025 do: 15 May 2025 •

Review meeting of Reporting Period 1 for the CTGCT

On May 15, 2024, the members of the CTGCT  hosted the review meeting for the Reporting Period 1of its EU-funded project at the Kemijski Inštitut in Ljubljana, in collaboration with representatives from its Advanced Partners

  • Events
  • Clinicians
  • Researchers
  • ATMPs
  • Regulation
  • Research
  • Rodrigo Ortiz
15 April 2025

ADVANCE 5-day Summer School on Cell and Gene Therapies

The next ADVANCE school on ATMP from Faculty of Pharmacy will happen here in Ljubljana. We think is a great FREE opportunity to learn more about ATMPs. Learn more in the official page of ...

Summer school
  • Events
  • Pacients
  • Business Model
  • Investment
  • CTGCT
  • NIC
  • Rodrigo Ortiz
13 March 2025 Event Date: 12 March 2025 do: 12 March 2025 •

Prime Minister of Slovenia Dr. Robert Golob visits the Kemijski Inštitut to discuss the CTGCT plans

Yesterday, Dr. Robert Golob, Prime Minister of the Slovenian Government, visited the Kemijski inštitut - National Institute of Chemistry.

Pxl 20250313 084506170.mp
  • Events
  • Clinicians
  • Researchers
  • Gen Therapy
  • Research
  • CTGCT
  • Rodrigo Ortiz
12 March 2025 Event Date: 17 March 2025 • 14:00 do: 17 March 2025 • 15:00

Gene Therapy: Triumphs, Challenges, and Future Directions

Lecture by Luis Pereira de Almeida on the 17th of March at the Kemijski Inštitut

Luis Pereira Lecture March 2025
  • Articles
  • Clinicians
  • Researchers
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • Manufacturing Process
  • Regulation
  • CTGCT
  • UMCUtrecht
  • Rodrigo Ortiz
5 March 2025

Navigating Viral Vector Production for Gene Therapy

This week we had the opportunity to listen to Ganesh Ramesh, a PhD candidate at the Viral Vector Production Center for Translation Immunology of UMC Utrecht, under the supervision of Dr. Zsolt Sebestyen. Here ...

Ctgct Scientific Talk March 2025
  • Articles
  • Pacients
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • Business Model
  • Economics
  • Pre Clinical
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
28 February 2025

How Patient Advocacy is Driving Breakthroughs to Treat CTNNB1 Syndrome

Imagine a world where a child’s genetic disorder, once considered untreatable, is finally on a path toward real solutions. For families affected by the CTNNB1 syndrome, that future is becoming a reality thanks to ...

Paving The Way Ctnnb1
  • Articles
  • Clinicians
  • Pacients
  • Researchers
  • ATMPs
  • Cell therapy
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
25 February 2025

Controlling Cells With Chemically Switchable Antibodies: A New Opportunity For Precision Therapy

Imagine being able to turn a cell’s behavior ON or OFF, just like flipping a light switch. That’s exactly what scientists have achieved with the innovative technology presented in this paper published in the ...

Graphical Abstract Controlling Cells
  • Articles
  • Pacients
  • Researchers
  • Gen Therapy
  • Laboratory
  • Pre Clinical
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
28 January 2025

The research on combining cytokines with pyroptosis is gaining widespread media coverage

Research on combining cytokines and pyroptosis for cancer therapy by Slovenian scientists has gained significant media recognition, including TV features, articles, and the honor of being named "Names of the Week".

Odmevi Sara N Iva
  • Media Releases
  • Pacients
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
10 January 2025

Head of CTGCT research selected as breakthrough discovery by the national TV in Slovenia

Check this video were he Head of the #CTGCT prof. dr. Mojca Benčina appeared in the news of the Slovenian national TV since her researched was selected as one of the breakthrough discoveries by ...

Mojca Rtve1 Discover Of The Year 2024

Posts pagination

1 2 3 4

Logo Foot

Center for the Technologies of Gene and Cell Therapies (CTGCT) is an infrastructure center  within the National Institute of Chemistry, Slovenia

Contact

  • +386 1 4760 335
  • info@ctgct.si
  • Hajdrihova 19, 1001 Ljubljana

Privacy policy

  • Cookies

Follow us

X Twitter Brands SolidX-twitter

LinkedIn

Bluesky Brands Solid Bluesky

Funding

 

Eu Logo

Ukri Logo

Ifeelslovenia Logo 400

Project: 101059842 – CTGCT – HORIZON-WIDERA-
Co-funded by the European Union, this project has received funding from Horizon Europe (grant agreement No. 101059842) and European Regional Development Fund EU under Slovenia’s Cohesion Policy Programme 2021-2027 (grant agreement No. C3360-25-952005) and the UK Research and Innovation (UKRI) under the UK government’s Horizon Europe funding guarantee (grant number 10069462). Views and opinions expressed are of the author(s) only and do not necessarily reflect those of the European Union or the European Research Executive Agency (REA). Neither the European Commission nor the granting authority can be held responsible for them.


CTGCT © 2026
Website production: Kreativna tovarna